No sides. Just data.

We compare what the media report with what the data say

Home › Today's contrasts › Health

Health · 2 outlets

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

Origin The Indian Express · 29/10 07:02 → 2 outlets in 1 h

Nothing to flag

All 2 outlets report the same figures and names, and there are no claims to check against official data. If that changes, the story comes back to the front page.

How each outlet tells it

Who does not report it

3 outlets

National outlets from the same country that published those days and have no piece in this story. Not an accusation: it may be an editorial choice.

NDTVScroll.inThe Times of India

Who reports it and how

2 stories
  1. The Indian Express 29/10 07:02 · National TB patients before patents: India rejects TB Alliance’s BPaL patent application
  2. The Hindu 29/10 07:52 · National Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

More contrasts in health

29/10/2026 07:02 – 29/10/2026 07:52 UTC · Analysis basis: texto completo · Methodology · Automatically produced, reviewable content. Headlines and short excerpts quoted with a link to the original outlet. The analysis is our own.